Taira S, Kakiuchi T, Minami M, Nariuchi H
J Immunol. 1986 Oct 15;137(8):2448-54.
Two different kinds of alloreactive T cell hybridomas were established in previous experiments. One is reactive and the other is nonreactive to allogeneic I-A region-associated membrane antigen (mIa) on B cells. In the present experiments the difference between these hybridomas were analyzed by using representative clones, B cell mIa-reactive clone CB-11.4, and nonreactive clone HTB-9.3. Unresponsiveness of HTB-9.3 clone to allogeneic B cells could not be due to the inability of B cells in interleukin 1 production or the density of mIa molecules on B cells. HTB-9.3 clone could respond to C57BL/6 mouse B cells treated with neuraminidase (Nase), and Nase-treated HTB-9.3 clone could respond to normal B cells from C57BL/6 mouse, indicating that sialic acid on both B cells and HTB-9.3 clone plays a regulatory role in the alloreactivity of the clone. In response to B cells from C57BL/6 mouse, T cells from C3H/He mouse spleen showed similar reactivity to HTB-9.3 clone; that is, T cells could respond to Nase-treated B cells, and Nase-treated T cells to B cells, and T cells primed with C57BL/6 spleen cells in vitro showed similar reactivity to CB-11.4 clone. These results suggest that HTB-9.3 clone represents virgin T cells and CB-11.4 clone-primed T cells at least in alloreactivity. Anti-L3T4a was shown to block alloreactivities of both T cell hybridomas and splenic T cells against B cells more efficiently than against splenic adherent cells. These results suggest that L3T4a on T cell plays more important role in allogeneic response to B cells than to splenic adherent cells.
在先前的实验中建立了两种不同的同种异体反应性T细胞杂交瘤。一种对B细胞上的同种异体I-A区相关膜抗原(mIa)有反应,另一种无反应。在本实验中,使用代表性克隆——B细胞mIa反应性克隆CB-11.4和无反应克隆HTB-9.3分析了这些杂交瘤之间的差异。HTB-9.3克隆对同种异体B细胞无反应,并非由于B细胞无法产生白细胞介素1或B细胞上mIa分子的密度所致。HTB-9.3克隆可对用神经氨酸酶(Nase)处理的C57BL/6小鼠B细胞产生反应,而用Nase处理的HTB-9.3克隆可对来自C57BL/6小鼠的正常B细胞产生反应,这表明B细胞和HTB-9.3克隆上的唾液酸在该克隆的同种异体反应性中起调节作用。针对来自C57BL/6小鼠的B细胞,C3H/He小鼠脾脏的T细胞表现出与HTB-9.3克隆相似的反应性;也就是说,T细胞可对用Nase处理的B细胞产生反应,用Nase处理的T细胞可对B细胞产生反应,并且在体外经C57BL/6脾细胞致敏的T细胞表现出与CB-11.4克隆相似的反应性。这些结果表明,至少在同种异体反应性方面,HTB-9.3克隆代表未致敏的T细胞,而CB-11.4克隆代表致敏的T细胞。结果显示,抗L3T4a阻断T细胞杂交瘤和脾T细胞对B细胞的同种异体反应性比阻断其对脾黏附细胞的同种异体反应性更有效。这些结果表明,T细胞上的L3T4a在对B细胞的同种异体反应中比在对脾黏附细胞的同种异体反应中发挥更重要的作用。